Intermittent hyperbaric oxygen therapy is shown to help reduce the cellular and biological aging of the body and effectively help us live longer and more important, healthier.
One of the effects seen during the aging process is a decline in cerebral blood flow, causing a reduction in brain oxygen levels. Cognitive and mental performance are effected, particularly in attention and information processing speed.
Hyperbaric oxygen therapy can help combat the decline in cognitive function by supplying the brain with a surplus of oxygen. In addition, the intermittent application of this procedure causes changes in oxygen tensions that promote promote beneficial regulatory protein changes (from the flux in oxygen levels from high to normal).
These changes include an increase in SIRT1, HIF-1A, and a reduction in CD28null senescent T helper and cytotoxic T cells.
- SIRT1 increases mitochondrial biogenesis (energy production) and attenuates telomere length thereby contributing to increased healthy life-span and reducing aging-related diseases.
- CD28null senescent T helper and cytotoxic T cells are aging-associated biomarkers and lower levels are associated with reduction in aging
- HIF-1A functions as a master regulator of cellular and systemic homeostatic response to hypoxia (low oxygen) by activating transcription of many genes, including those involved in energy metabolism, angiogenesis (creation of new blood vessels and circulation) and much more
As you can see, hyperbaric oxygen therapy produces numerous benefits for helping to counteract the negative effects seen from the aging process <view study>